Abstract:Background: Dysregulation of prostate stem cell antigen (PSCA) has been implicated in human cancers. Studies have reported that PSCA expression is generally high in prostate cancer, which correlates with a worse survival. PSCA is also highly expressed in bladder, ovarian, and pancreatic cancers. However, PSCA is expressed at low levels in gastric, gallbladder and oesophageal cancers. At present, the clinical significance, expression pattern and biological function of PSCA in gastric cancer (GC) are still unclear. Methods: Previously, we used cDNA microarray as a screening tool to compare GC tissues with its matched normal gastric mucosa tissues (MNGT), and obtained the differentially expressed genes of the two tissue types. PSCA is one of the genes significantly down-regulated in GC tissues. In this study, we detected the expression of PSCA in GC tissues and MNGT by western-blot experiment and immunohistochemical staining (IHC). Then the relationship between the expression pattern of PSCA and the clinicopathological characteristics and survival in GC was analyzed. In order to further study the function of PSCA in GC, lentivirus was used to construct stable cell lines with knockdown and overexpression of PSCA gene. We used AGS and MKN45 cell lines for plasmid transfection. Colony formation assay, MTS and nude mice xenograft model were performed to investigate the effect of PSCA in GC. Results: Western-blot and IHC assays demonstrated that the expression of PSCA in GC tissues was significantly lower than that in the MNGT. PSCA expression in GC tissues was high in 252 (57.5%) and low in 186 (42.5%) of 438 patients. PSCA expression for MNGT was high in 273 (62.3%) and low in 165 (37.7%) of 438 patients. PSCA expression was significantly associated with T classification (P=0.024), N classification (P=0.018) and TNM stage (P=0.019) using χ2 test. The relationship between PSCA expression level and patient survival was analysed using Kaplan-Meier analysis and the log-rank test. Low levels of PSCA expression were significantly associated with a poorer OS than high expression levels of PSCA (P=0.011). In the COX regression analysis of OS, all 9 variables in the univariate analysis were significantly correlated with OS (P<0.05), while the variables found to be independently correlated with OS in the multivariate analysis were PSCA expression (P=0.036), age (P<0.001), gender (P=0.007), and TNM stage (P<0.001), respectively. Univariate and multivariate analyses showed that PSCA was an independent prognostic factor for OS in GC. In vitro MTS cell proliferation experiment and clonal formation experiment and in vivo nude mouse subcutaneous tumorigenesis experiment all proved that knockdown of PSCA gene can improve the proliferation ability of GC cells, while in vitro experiment proved that overexpression of PSCA can reduce the proliferation ability of GC cells.It was found that knockdown of PSCA gene can improve the proliferation ability of GC cells both in vitro and in vivo, while overexpression of PSCA can reduce the proliferation ability of GC cells in vitro. Conclusion: Our study showed that the expression of PSCA gene was decreased in GC, which was related to more advanced pathological stages. And the expression level of PSCA in GC was an independent good prognostic factor. PSCA gene had the function of inhibiting GC proliferation.

Expression of Stem Cell Markers Nanog and Psca in Gastric Cancer and Its Significance

Detection of stem cell marker Nanog and diagnostic significance for human gastric cancer

Expression of Ngf Family and Their Receptors in Gastric Carcinoma: A Cdna Microarray Study

Clinical significance of putative markers of cancer stem cells in gastric cancer: A retrospective cohort study.

Association of High Expression Levels of SOX2, NANOG, and OCT4 in Gastric Cancer Tumor Tissues with Progression and Poor Prognosis

Stem Cell Landscape Aids in Tumor Microenvironment Identification and Selection of Therapeutic Agents in Gastric Cancer.

The human pluripotency gene NANOG/NANOGP8 is expressed in gastric cancer and associated with tumor development

Stem Cell Associated Genes Working with One MiRNA Cluster Have Different Clinic Pathologic Values in Gastric Cancer

Role of CD97stalkand CD55 As Molecular Markers for Prognosis and Therapy of Gastric Carcinoma Patients

[Expression of Tissue Microarray P53, P16 and Cyclooxygenase-2 in Gastric Cancer].

Aberrant Expression of Markers of Cancer Stem Cells in Gastric Adenocarcinoma and Their Relationship to Vasculogenic Mimicry

The expression and clinical significance of stem cell transcription factor SOX2, OCT4 in gastric ;cancer tissues varying degrees of cell differentiation

Identification Of Stem-Like Cells And Clinical Significance Of Candidate Stem Cell Markers In Gastric Cancer

Nanog, A Novel Prognostic Marker for Lung Cancer

Downregulation of PSCA Promotes Gastric Cancer Proliferation and is Related to Poor Prognosis.

Clinicopathological and Prognostic Significance of Cancer Stem Cell Markers CD44 and CD133 in Patients with Gastric Cancer

The Potential Prognostic Value of Expression of Stem Cell Marker of CD44s, EpCAM, and OVA66 in Patients with Gastric Adenocarcinoma.

Expression of Stem Cell Related Transcription Factors 3, High-Mobility Group Box 1, and Stem Cell Markers Nanog and Their Significance in Cervical Cancer

Expression and Significance of Prostate Stem Cell Antigen and Oct-4 in Benign and Malignant Lesions of the Stomach

Expression of Oct-4 in gastric carcinoma and its clinical significance

Expression of OCT4,SOX2 and Nanog and its significance in cervical cancer